Table 2

IPA in mother's blood and the survival of mother's lymphocytes in patient's blood

CaseMother's PBMCs infused per infusion, ×108/kgIPAs in mother's blood*Ratio of NIMAs in patient's blood before the infusion*Ratio of NIMAs in patient's blood after the infusion*
1; 4 infusions in total SRY+Negative 4 days after the first infusion: 10−3.9
 1.3 10−5.15 by quantification  8 days after the first infusion: none 
 1.0    
 1.1    
2; 4 infusions in total 6.8 SRY+  
 5.7 10−4.12 by quantification   
 3.6    
    
3; 2 infusions in total 1.1 SRY+10−3.13 5 days after the first infusion: 10−2.84
 1.0   13 months after the first infusion: 10−4.92 
3.5 SRY+; 10−4.67 by quantification   
1.7 SRY+;  10−2.33 4 days after the first infusion:10−2.46; 42 days after the first infusion:10−2.61 
CaseMother's PBMCs infused per infusion, ×108/kgIPAs in mother's blood*Ratio of NIMAs in patient's blood before the infusion*Ratio of NIMAs in patient's blood after the infusion*
1; 4 infusions in total SRY+Negative 4 days after the first infusion: 10−3.9
 1.3 10−5.15 by quantification  8 days after the first infusion: none 
 1.0    
 1.1    
2; 4 infusions in total 6.8 SRY+  
 5.7 10−4.12 by quantification   
 3.6    
    
3; 2 infusions in total 1.1 SRY+10−3.13 5 days after the first infusion: 10−2.84
 1.0   13 months after the first infusion: 10−4.92 
3.5 SRY+; 10−4.67 by quantification   
1.7 SRY+;  10−2.33 4 days after the first infusion:10−2.46; 42 days after the first infusion:10−2.61 
*

Quantification of microchimerism by specific insertion/deletion polymorphism method.

We used 9 insertion/deletion polymorphisms, trying to identify the polymorphism specific for IPAs or NIMAs, but no such insertion/deletion polymorphism was found. Therefore, quantification of microchimerism could not be conducted.

or Create an Account

Close Modal
Close Modal